Immuron Limited (ASX:IMC)
0.0330
+0.0030 (10.00%)
At close: Mar 26, 2026
Immuron Market Cap
Immuron has a market cap or net worth of 10.78 million as of March 27, 2026. Its market cap has decreased by -47.55% in one year.
Market Cap
10.78M
Enterprise Value
988.16K
Revenue
7.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 10.78M, a decrease of -71.11%. That is a compound annual growth rate of -4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 10.78M | -8.01% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 17.82M |
| Patrys | 16.06M |
| Bio-Gene Technology | 10.68M |
| AdAlta | 10.20M |
| Tissue Repair | 9.37M |
| Chimeric Therapeutics | 8.84M |
| Biotron | 8.11M |
| Vectus Biosystems | 8.02M |